๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Responsiveness of patients with advanced ovarian carcinoma to tamoxifen. A gynecologic oncology group study of second-line therapy in 105 patients

โœ Scribed by Kenneth D. Hatch; Jackson B. Beecham; John A. Blessing; William T. Creasman

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
223 KB
Volume
68
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Glutathione concentration may be a usefu
Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer
โœ Junzo Kigawa; Yukihisa Minagawa; Yasunobu Kanamori; Hiroaki Itamochi; Xiusi Chen ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 162 KB ๐Ÿ‘ 2 views

in tumor samples was determined by immunohistochemical staining and Western blot analysis. GSH concentration was measured by an enzymatic assay. Department of Obstetrics and Gynecology, Tot- ## RESULTS. The response rate was 38.4%. The estimated 3-year survival rate for tori University School of

A phase II trial of interferon-ฮฑ and 5-f
A phase II trial of interferon-ฮฑ and 5-fluorouracil in patients with advanced renal cell carcinoma: A Southwest Oncology Group study
โœ Laurence Elias; Brent A. Blumenstein; Julie Kish; Robert C. Flanigan; James L. W ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 355 KB ๐Ÿ‘ 1 views

## BACKGROUND. Renal cell carcinoma is a common neoplasm that is often refractory to treatment. It is occasionally responsive to immunoniodulating agents including interferon-a, which enhances the effects of 5-fluorouracil upon cells. Combinations of these two drugs have been most frequently tested

Evaluation of low dose continuous infusi
Evaluation of low dose continuous infusion 5-fluorouracil in patients with advanced and recurrent renal cell carcinoma. A Southwest Oncology Group study
โœ Julie A. Kish; Michael Wolf; E. David Crawford; Joseph T. Leimert; Anton Buesche ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 289 KB ๐Ÿ‘ 2 views

Background. The response rate of metastatic renal cell cancer to cytotoxic therapy over the last 10 years has been 5.6%. Low dose continuous 5-fluorouracil(5-FU) has demonstrated efficacy in other cytotoxic refractory tumors, such as pancreas, colorectal, and recurrent breast. The Southwest Oncology

Phase II study of pemetrexed disodium, a
Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma : A study of the national cancer institute of Canada clinical trials group
โœ Frances A. Shepherd; Janet Dancey; Andrew Arnold; Alan Neville; James Rusthoven; ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB ๐Ÿ‘ 2 views

## Background: Pemetrexed disodium (alimta [eli lilly and company, indianapolis, in], ly231514, multitargeted antifolate) is a new multitargeted antifolate agent that inhibits multiple enzymes in the folate pathway. phase ii trials showed single-agent response rates of 16% and 23% in untreated pati

Responses to chemotherapy or chemohormon
Responses to chemotherapy or chemohormonal therapy in advanced breast cancer patients treated previously with adjuvant chemotherapy: A subset analysis of CALGB study 8081
โœ Carl G. Kardinal; Michael C. Perry; Ann H. Korzun; Mary Alice Rice; Sandra Ginsb ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 399 KB ๐Ÿ‘ 2 views

The Cancer and Leukemia Group B (CALGB) evaluated the response to subsequent chemotherapy or chemohormonal therapy in 46 patients with advanced breast cancer treated previously with adjuvant chemotherapy that had been completed 6 months or more before protocol entry. The results were compared with 3